At HealthSky, our mission has always been to drive innovation in pathology and deliver accessible, high-precision diagnostic solutions worldwide. We were recently honored to present HealthSky's end-to-end cervical cytology ecosystem, sharing our technological advancements and real-world clinical experience from China with healthcare professionals across the region.
China and Vietnam, like many rapidly developing countries, face remarkably similar public health challenges regarding cervical cancer screening:
Large Screening Populations: High volumes of routine screening require efficient, high-throughput diagnostic workflows.
Growing Clinical Demand: Increased health awareness has led to higher testing rates, putting pressure on existing healthcare infrastructure.
Pathology Resource Constraints: The scarcity and uneven geographic distribution of experienced pathologists remain significant bottlenecks.
These shared challenges are driving a necessary transition toward digital cytology and creating a compelling demand for AI-assisted diagnostic tools in daily clinical workflows.
To address these pain points, HealthSky offers a comprehensive, automated, and intelligent solution designed to streamline the entire cervical screening pipeline:
SCTE-3600A Fully Automated LBC Workstation
Standardizes sample processing with high precision, ensuring consistent slide preparation and high-quality liquid-based cytology (LBC) results.
iScanner Whole Slide Imaging System
Delivers high-resolution, fast digital scanning of slide specimens, creating high-definition digital slides for seamless remote analysis and archiving.
Patho.AI (AI-Assisted Cytology Solution)
Powered by deep-learning algorithms, Patho.AI assists pathologists by pre-screening, highlighting suspicious areas, and accelerating diagnostic workflows.
The Power of Digital Cytology & Responsible AI Integration
Digital cytology holds immense potential to transform routine pathology. By converting physical slides into digital assets and pairing them with intelligent algorithm pre-screening, healthcare providers can significantly improve diagnostic efficiency while reducing the risk of missed abnormalities.
However, successful clinical adoption requires a balanced approach. While AI excels at rapid feature detection and screening support, it is designed to empower—not replace—the pathologist. Recognizing the current boundaries of AI and applying it strictly within validated clinical frameworks is paramount to ensuring patient safety, diagnostic accuracy, and ethical healthcare delivery.
Collaborating for a Healthier Future Across Southeast Asia
The exchange in Vietnam highlighted the immense potential for cross-border collaboration in digital pathology. By sharing clinical practices, data insights, and automated technologies, we hope to support our colleagues in Vietnam and neighboring regions as they advance their cervical cancer screening initiatives.
HealthSky remains committed to expanding our partnerships across Southeast Asia. Together with regional healthcare institutions and industry partners, we aim to accelerate the digital transformation of pathology and bring accurate, AI-assisted screening to every patient who needs it.
EN
jp 
ko 
fr 
de 
pt 
ar 
es 
ru 
fa 
id 
